Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis

<table>Forest plot of pooled data on DL<sub>CO</sub> prior (favours control arm) and during treatment with MMF or MS (favours MMF or MS arm). Abbreviations: CI: Confidence Interval, DL<sub>CO</sub>: Diffusing Capacity for carbon monoxide, MMF: Mycophenolate mofetil, MS: Mycophenolate Sodium, SD: Standard deviation.</table>

Pulmonary Medicine

fig2

Figure 2

Figure 2: Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis 